The rating affirmation reflects ThedaCare’s continued operating revenue growth, adequate balance sheet metrics and leading market share. ThedaCare also faces several challenges, including a competitive broader market.
The outlook is stable, acknowledging ThedaCare’s sufficient liquidity position, continued revenue growth and solid market share.
More articles on healthcare finance:
S&P downgrades Mercy Health’s rating to ‘A+’
Opinion: Paul Ryan’s high-risk insurance pools are far too risky
S&P lowers rating to ‘BBB+’ on Lawrence + Memorial Hospital’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
